早期非小细胞肺癌肺叶切除与肺段切除的患者报告结局比较
该观察性队列研究纳入248例肿瘤直径≤2 cm的早期非小细胞肺癌患者,均接受单孔胸腔镜手术,比较肺叶切除(92例)与肺段切除(156例)的早期术后患者报告症状与功能状态。两组在7项症状和2项功能条目上均无显著差异(所有P>0.05),中重度症状恢复时间及短期临床结局也相似。结论认为两种术式早期术后负担相近,结合长期肿瘤学与功能证据,肺段切除是该人群的适宜选择。
要点
- 肿瘤直径≤2 cm的早期NSCLC行单孔VATS时,肺叶与肺段切除的早期症状和功能负担相似。
- 两组7项症状和2项功能条目比较均无显著差异(所有P>0.05)。
- 中重度症状恢复时间及短期临床结局(手术时间、住院、引流、并发症等)无显著差异。
核心结论
- 对于肿瘤直径≤2 cm的早期NSCLC行单孔VATS,肺叶切除与肺段切除的早期术后症状/功能负担、恢复时间及短期结局基本相似。
- 结合外部长期肿瘤学与功能证据,肺段切除是该患者人群高度适宜的选项。
研究设计与样本
- 使用肺手术患者围术期症状评估量表,于术前1天、术后第1-4天每日及术后第1-4周每周收集患者报告结局。
主要发现
- 两组早期术后症状和功能状态相当,7项症状条目和2项功能条目均无显著差异(所有P>0.05)。
- 两组中重度症状和功能损害恢复时间相似。
- 短期临床结局包括手术时间、术后住院时间、引流时间、出院评分和并发症发生率均无统计学显著差异(所有P>0.05)。
临床怎么用
- 对于肿瘤直径≤2 cm的早期NSCLC,肺段切除可作为与肺叶切除相当的术式选择,早期术后症状负担无明显差异。
- 决策时应结合长期肿瘤学结局和功能证据综合考量,而非仅依据早期患者报告结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Surgical resection is the cornerstone for early-stage non-small cell lung cancer (NSCLC), with lobectomy historically standard. Evolving techniques have spurred debate comparing lobectomy and segmentectomy. This study analyzed early postoperative patient-reported symptoms and functional status in patients with early NSCLC undergoing either procedure. METHODS: This observational cohort study included 248 patients (Lobectomy = 92, Segmentectomy = 156) with early-stage NSCLC (tumor diameter ≤ 2 cm) who underwent uniport video-assisted thoracoscopic surgery (VATS), from December 2021 to December 2023. Patient-reported outcomes were collected using the Perioperative Symptom Assessment for Patients Undergoing Lung Surgery scale at preoperative day 1, daily from postoperative days 1-4, and weekly for postoperative weeks 1-4. We compared early postoperative symptom/functional impairment scores, recovery time from moderate-to-severe symptoms, and short-term clinical outcomes. RESULTS: Both groups exhibited comparable early postoperative symptoms and functional status. No significant differences were observed between the two groups in any of the 7 symptom items or the 2 function items (all P > 0.05). The time to recovery from moderate-to-severe symptoms and functional impairment was also similar between the groups. Furthermore, there were no statistically significant differences in short-term clinical outcomes, including operative time, postoperative hospital stays, drainage time, discharge scores, or complication rates (all P > 0.05). CONCLUSION: For early-stage NSCLC (tumor diameter ≤ 2 cm) undergoing uniport VATS, lobectomy and segmentectomy yield largely similar early postoperative symptom/functional burden, recovery times, and short-term outcomes. Considering external evidence on long-term oncology and function, segmentectomy is supported as a highly suitable option for this patient population.
引用
- Hong Q, Wang Y, Ma F, et al. Patient-reported outcomes after lobectomy vs. segmentectomy for early-stage non-small cell lung cancer. Surg Endosc. 2025. PMID: 40926159. doi:10.1007/s00464-025-12172-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。